Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Aerovate Therapeutics IncCommon Stock stock

Learn how to easily invest in Aerovate Therapeutics IncCommon Stock stock.

Aerovate Therapeutics, Inc. Common Stock
NASDAQ: AVTE - USD
BIOTECHNOLOGY
$12.85
-$0.23 (-1.76%)

Aerovate Therapeutics, Inc. Common Stock is a biotechnology business based in the US. Aerovate Therapeutics IncCommon Stock shares (AVTE) are listed on the NASDAQ and all prices are listed in US Dollars. Aerovate Therapeutics IncCommon Stock employs 7 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Aerovate Therapeutics IncCommon Stock

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AVTE – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Aerovate Therapeutics IncCommon Stock stock price (NASDAQ: AVTE)

Use our graph to track the performance of AVTE stocks over time.

Aerovate Therapeutics IncCommon Stock shares at a glance

Information last updated 2021-07-28.
52-week range$11.72 - $29.43
50-day moving average $15.97
200-day moving average $15.97
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy Aerovate Therapeutics IncCommon Stock shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Aerovate Therapeutics IncCommon Stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Aerovate Therapeutics IncCommon Stock financials

Gross profit TTM $0
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Book value N/A
Market capitalisation $306.2 million

TTM: trailing 12 months

Shorting Aerovate Therapeutics IncCommon Stock shares

There are currently 416,828 Aerovate Therapeutics IncCommon Stock shares held short by investors – that's known as Aerovate Therapeutics IncCommon Stock's "short interest". This figure is up from 0 last month.

There are a few different ways that this level of interest in shorting Aerovate Therapeutics IncCommon Stock shares can be evaluated.

Aerovate Therapeutics IncCommon Stock's "short interest ratio" (SIR)

Aerovate Therapeutics IncCommon Stock's "short interest ratio" (SIR) is the quantity of Aerovate Therapeutics IncCommon Stock shares currently shorted divided by the average quantity of Aerovate Therapeutics IncCommon Stock shares traded daily (recently around 182819.29824561). Aerovate Therapeutics IncCommon Stock's SIR currently stands at 2.28. In other words for every 100,000 Aerovate Therapeutics IncCommon Stock shares traded daily on the market, roughly 2280 shares are currently held short.

To gain some more context, you can compare Aerovate Therapeutics IncCommon Stock's short interest ratio against those of similar companies.

However Aerovate Therapeutics IncCommon Stock's short interest can also be evaluated against the total number of Aerovate Therapeutics IncCommon Stock shares, or, against the total number of tradable Aerovate Therapeutics IncCommon Stock shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aerovate Therapeutics IncCommon Stock's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Aerovate Therapeutics IncCommon Stock shares in existence, roughly 20 shares are currently held short) or 2.9505% of the tradable shares (for every 100,000 tradable Aerovate Therapeutics IncCommon Stock shares, roughly 2951 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Aerovate Therapeutics IncCommon Stock.

Find out more about how you can short Aerovate Therapeutics IncCommon Stock stock.

Aerovate Therapeutics IncCommon Stock share dividends

We're not expecting Aerovate Therapeutics IncCommon Stock to pay a dividend over the next 12 months.

Aerovate Therapeutics IncCommon Stock overview

Aerovate Therapeutics, Inc. , a clinical stage biopharmaceutical company, focuses on developing drugs that enhance the lives of patients with rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was incorporated in 2018 and is headquartered in Boston, Massachusetts. .

Frequently asked questions

What percentage of Aerovate Therapeutics IncCommon Stock is owned by insiders or institutions?
Currently 26.84% of Aerovate Therapeutics IncCommon Stock shares are held by insiders and 45.816% by institutions.
How many people work for Aerovate Therapeutics IncCommon Stock?
Latest data suggests 7 work at Aerovate Therapeutics IncCommon Stock.
When does the fiscal year end for Aerovate Therapeutics IncCommon Stock?
Aerovate Therapeutics IncCommon Stock's fiscal year ends in December.
Where is Aerovate Therapeutics IncCommon Stock based?
Aerovate Therapeutics IncCommon Stock's address is: 200 Berkeley Street, Boston, MA, United States, 02116

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site